Crossmark

Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study

Crossref DOI link: https://doi.org/10.1007/s00415-014-7395-7

Published Online: 2014-06-28

Published Print: 2014-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Miller, Aaron E.

Macdonell, Richard

Comi, Giancarlo

Freedman, Mark S.

Kappos, Ludwig

Mäurer, Mathias

Olsson, Tomas P.

Wolinsky, Jerry S.

Bozzi, Sylvie

Dive-Pouletty, Catherine

O’Connor, Paul W.
License Information

License valid from 2014-06-28